A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.
Cardiovascular disease is often associated with chronic obstructive pulmonary disease (COPD). A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.
The research, published in the International Journal of Chronic Obstructive Pulmonary Disease, included data from the German COPD cohort COSYCONET (COPD and Systemic Consequences—Comorbidities Network). Lung function data was collected including forced expiratory volume in 1 second (FEV1) and echocardiographic data on the left ventricular ejection fraction (LVEF) and end-diastolic diameter (LVEDD).
“The diagnosis of the predominant underlying disease and its contribution to COPD symptoms remains challenging. The situation is complicated by the fact that, even when objective measures of heart function are available, they do not necessarily correlate with the magnitude of symptoms,” the authors explained. “In addition, patients may receive cardiovascular medication, which may alleviate symptoms to a variable degree, depending on the type and severity of cardiac disease. Moreover, the indication that led to medication in the past might not be verifiable at a later time.”
In total, 1591 patients were included and evaluated in the study. In 289 of these patients, ischemic heart disease, myocardial infarction or heart failure was reported, while 860 patients had received at least one cardiovascular medication. Furthermore, of the 948 patients without isolated hypertension, 38% had LVEF <50% and 53.4% with LVEDD>56 mm, who lacked cardiac diagnosis and medication.
In addition, the researchers found that LVEDD and LVEF were linked to medical history, as LVEDD as dependent on residual volume/total lung capacity and LVEF on FEV1.
“The present study revealed a substantial prevalence of cardiac disease in patients with stable COPD, in accordance with previous findings. At least one of the three selected cardiac disorders was reported by about one-fifth of the patients, while the rate of suspicious echocardiographic left heart findings was lower,” concluded the authors. “The overlap between reported cardiac history and abnormal echocardiography was low, and only a minority of patients with a respective history exhibited an impaired left ventricular systolic function or dilatation.”
Due to the results, the researchers suggest that the direct assessment of heart size and function is likely to be more reliable in the detection of concomitant cardiac disease in COPD patients.
Reference
Alter P, Mayerhofer BA, Kahnert K, et al. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort [published online September 20, 2019]. International Journal of Chronic Obstructive Pulmonary Disease. doi.org/10.2147/COPD.S209343.
Drug Overdoses Leading to Cardiac Arrest Rising, Particularly With Stimulant-Opioid Combination
November 25th 2023A population-based study found that out-of-hospital cardiac arrest events resulting from drug overdoses have significantly increased from 2015 to 2021, particularly among patients who have taken a combination of stimulants and opioids.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
COPD Prevalence Did Not Significantly Change Overall From 2011 to 2021, Study Says
November 21st 2023Based on Behavioral Risk Factor Surveillance System data, about 6.4% of US adults in 2011 (14.3 million people) and about 6.5% (14.2 million) had COPD in 2021, showing that COPD prevalence did not significantly change throughout the decade.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
New Study Links Sphingolipids With Palmitic Acid to Increased Risk of Sudden Cardiac Death
November 17th 2023Plasma ceramides and sphingomyelins with palmitic acid were linked to a 34% and 37% increased risk of sudden cardiac death (SCD) per higher SD of log sphingolipid levels, respectively.
Read More